Overview

Infectious Disease Testing Market Introduction:

 Global infectious disease testing market to achieve beyond $24 billion mark by 2027 end, registering a CAGR of 5.8% during  the forecast period of 2020-2027.

Infectious disease is caused by bacteria, virus and others and has a huge impact on healthcare systems of the countries. Infectious disease testing is the process of identification of causative organism for the primary diagnosis of diseases.Infectious diseases testing samples include blood, urine and other bodily fluids. Diagnosis is primary requisite for disease management, so infectious disease testing plays a very important role in primary healthcare settings.

Increasing epidemics of infectious diseases require continuous testing and led robust growth of the market.  Infectious diseases have a huge impact on healthcare systems due to high disease burden. Because of this, government bodies made it mandatory to run infectious disease testing across different domains. It created potential opportunities for infectious disease testing manufacturers and boosted the growth of the market. Further, changing regulatory policies to mandate the infectious disease testing for the general population fuelled the growth of the market. Along with these, technology has integrated the existing manual operations and led to the development of a fully automated process. Others factors like increasing awareness among the general population regarding the drastic effects of infectious diseases have boosted the robust growth of the infectious disease testing market. 

Developing economies made it mandatory for testing the general population regarding the infectious disease epidemics has boosted the growth of North America and Europe. North America infectious disease testing market accounts major share in the global market due to high penetration among the end users. It is followed by Europe and it witnessed a significant share due to stringent government policies. Asia Pacific and Latin America Infectious Disease Testing market is the most lucrative space for manufacturers due to high prevalence of infectious diseases.  Rest of the world witnessed significant growth during the forecast period due to increasing awareness. 

Infectious disease testing manufacturers include Abbott Laboratories, Becton, Dickinson And Company, Biomérieux Sa, Bio-rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific.

Impact of COVID-19 on Infectious Disease Testing Market:

Many diagnostic test manufacturers have initiated to develop and commercialize devices that facilitate testing procedures outside lab settings. These kits are capable of detecting COVID-19 proteins from the respiratory samples such as throat swab and sputum or through serum or blood. But WHO has recommended to use these point-of-care tests specifically in research settings. The rapid diagnostic testing is capable of detecting the presence of antigens of the novel coronavirus from a respiratory tract sample. Such advancements shall contribute in the market growth.               

Infectious Disease Testing Market Segmentation 

By Product & Service 

  • Assays, Kits, & Reagents
  • Instruments
  • Services & Software

By Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction (Pcr)
  • Isothermal Nucleic Acid Amplification Technology (Inaat)
  • Dna Sequencing & Next-generation Sequencing (Ngs)
  • Dna Microarray
  • Other Technologies

By Disease Type

  • Hepatitis
  • Human Immunodeficiency Virus (Hiv)
  • Chlamydia Trachomatis Genital Infection And Gonorrhea (Ct/Ng)
  • Hospital-acquired Infections (Hais)
  • Human Papillomavirus (Hpv)
  • Tuberculosis (Tb)
  • Influenza
  • Others

By End User

  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Physician Offices
  • Academic/Research Institutes
  • Others

By Region 

  • Europe  
  • North America  
  • APAC  
  • Latin America
  • Rest of World 

Competitive Landscape:  

  • Tier 1 players- established companies in the market with a major market share  
  • Tier 2 players 
  • Emerging players which are growing rapidly 
  • New Entrants   

FutureWise Takeaways  

  • Growth prospects  
  • SWOT analysis 
  • Key trends 
  • Key data-points affecting market growth  

Objectives of the Study: 

  • To provide with an exhaustive analysis on the global infectious disease testing market  on the basis of product & service, technology,  disease type, end user and region   
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) 
  • To evaluate and forecast micro-markets and an overall market  
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East 
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics